Lowenstein represented Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, in its $75 million Series C funding round, led by new investor SoftBank Vision Fund 2, with participation from ArrowMark Partners and existing investors Octopus Ventures, Gilde Healthcare, Kaiser Permanente Ventures (KPV), and Morningside Ventures.

Big Health’s mission is to provide safe and effective non-drug alternatives for the most common mental health conditions including insomnia and anxiety. By seamlessly integrating across the care pathway, from member engagement to billing via pharmacy benefit managers, Big Health simplifies adoption for both payers and patients, providing an inclusive, scalable, and affordable approach without serious side effects. Big Health’s new funding will accelerate the company’s commercial reimbursement model and product platform, including six new digital therapeutics by 2024.

The Lowenstein team included Kathi A. Rawnsley, Chad M.P. Weeks, Rahul J. Devnani, and Kelsey Repka.

About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, New Jersey, Palo Alto, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.

Contact(s):
Penny Paul
Sr. Manager, Marketing Communications
Lowenstein Sandler LLP
(973) 597-2592
ppaul@lowenstein.com